Search research articles
Contact Us
Filters
Showing results (41-50 of 276) with videos related to
Page
of 28
Sort By:
Cancer Immunology, Immunotherapy : CII
|
April 24, 2014
Extracellular adenosine metabolism in immune cells in melanoma
Viktor Umansky, Ivan Shevchenko, Alexandr V Bazhin, et al.
Expert Opinion on Therapeutic Targets
|
October 28, 2018
Targeting SOX2 in anticancer therapy
Laura Hüser, Daniel Novak, Viktor Umansky, et al.
Stem Cells (Dayton, Ohio)
|
July 19, 2008
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression
Sarah Eminli, Jochen Utikal, Katrin Arnold, et al.
Science (New York, N.Y.)
|
September 27, 2008
Induced pluripotent stem cells generated without viral integration
Matthias Stadtfeld, Masaki Nagaya, Jochen Utikal, et al.
Cancers
|
January 8, 2020
STAT3 Relays a Differential Response to Melanoma-Associated <i>NRAS</i> Mutations
James Kim, Daniel Novak, Christos Sachpekidis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2014
Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letter
Mathias Bernhardt, Elias Orouji, Lionel Larribere, et al.
Cancer Treatment Reviews
|
June 7, 2021
NRAS mutant melanoma: Towards better therapies
Tijana Randic, Ines Kozar, Christiane Margue, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 15, 2005
[90-year-old male with a hyperkeratotic lichenoid skin eruption]
Ute Bauer, Selma Ugurel, Jochen Utikal, et al.
Seminars in Cancer Biology
|
July 21, 2015
Function and significance of MicroRNAs in benign and malignant human stem cells
Jochen Utikal, Mohammed Abba, Daniel Novak, et al.
Acta Dermato-Venereologica
|
April 9, 2014
Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib
Christoffer Gebhardt, Janina Staub, Astrid Schmieder, et al.
Page
of 28
Search research articles
Search
Showing results (41-50 of 276) with videos related to
Sort By:
Page
of 28
Cancer Immunology, Immunotherapy : CII
|
April 24, 2014
Extracellular adenosine metabolism in immune cells in melanoma
Viktor Umansky, Ivan Shevchenko, Alexandr V Bazhin, et al.
Expert Opinion on Therapeutic Targets
|
October 28, 2018
Targeting SOX2 in anticancer therapy
Laura Hüser, Daniel Novak, Viktor Umansky, et al.
Stem Cells (Dayton, Ohio)
|
July 19, 2008
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression
Sarah Eminli, Jochen Utikal, Katrin Arnold, et al.
Science (New York, N.Y.)
|
September 27, 2008
Induced pluripotent stem cells generated without viral integration
Matthias Stadtfeld, Masaki Nagaya, Jochen Utikal, et al.
Cancers
|
January 8, 2020
STAT3 Relays a Differential Response to Melanoma-Associated <i>NRAS</i> Mutations
James Kim, Daniel Novak, Christos Sachpekidis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2014
Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letter
Mathias Bernhardt, Elias Orouji, Lionel Larribere, et al.
Cancer Treatment Reviews
|
June 7, 2021
NRAS mutant melanoma: Towards better therapies
Tijana Randic, Ines Kozar, Christiane Margue, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 15, 2005
[90-year-old male with a hyperkeratotic lichenoid skin eruption]
Ute Bauer, Selma Ugurel, Jochen Utikal, et al.
Seminars in Cancer Biology
|
July 21, 2015
Function and significance of MicroRNAs in benign and malignant human stem cells
Jochen Utikal, Mohammed Abba, Daniel Novak, et al.
Acta Dermato-Venereologica
|
April 9, 2014
Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib
Christoffer Gebhardt, Janina Staub, Astrid Schmieder, et al.
Page
of 28